Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

E-ISSN： 1873-4286|23|33|4936-4947

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.33, 2018-01, pp. : 4936-4947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1305-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies

By Vekrellis Kostas Stefanis Leonidas

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 421-432

Informa Healthcare

Access to resources Recommend Favorite

Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 693-702

Bentham Science Publishers

Access to resources Recommend Favorite

Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 273-281

Bentham Science Publishers

Access to resources Recommend Favorite

Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States

Current Pharmaceutical Design, Vol. 12, Iss. 5, 2006-02 ,pp. : 615-638

Bentham Science Publishers

Access to resources Recommend Favorite